Source link : https://newshealth.biz/health-news/combo-therapy-for-myelodysplastic-syndromes-misses-survival-goal-in-randomized-trial/
(MedPage Today) — HOUSTON — Survival in untreated, intermediate- and higher-risk myelodysplastic syndromes (MDS) failed to improve with the addition of the targeted agent venetoclax (Venclexta) to chemotherapy, a large randomized trial showed… Source link : https://www.medpagetoday.com/meetingcoverage/soho/117342 Author : Publish date : 2025-09-06 17:16:00 Copyright for syndicated content belongs to the linked Source.
The post Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-06 17:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8